Rights and permissions
About this article
Cite this article
Advair blows off strong competition to remain first choice. Pharmacoecon. Outcomes News 603, 11 (2010). https://doi.org/10.2165/00151234-201006030-00027
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201006030-00027